Myelofibrosis: Clinical Trials

2 trials for Myelofibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Unknown 1

Follow Myelofibrosis: new trials by email Literature Review of Myelofibrosis trials Research Report on Myelofibrosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts
Momelotinib, Ruxolitinib - Myelofibrosis, Myelofibrosis (MF)
Phase 4Not yet recruitingSWOG Cancer Research Network2682026-11-012026-09-17
A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis
Ruxolitinib - Myelofibrosis
Phase 4UnknownQilu Hospital of Shandong University872022-06-102022-07-07

Narrower conditions

Primary Myelofibrosis (2)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Myeloproliferative Disorders (2)

Interventions

ruxolitinib (2)  ·  N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide (1)

Sponsors

Qilu Hospital of Shandong University (1)  ·  SWOG Cancer Research Network (1)

Countries

China (1)

Top investigators

Alexander Coltoff, MD (1)